Global Health Limited

NSE MEDANTA.NS

Global Health Limited Operating Cash Flow for the year ending March 31, 2024: USD 73.38 M

Global Health Limited Operating Cash Flow is USD 73.38 M for the year ending March 31, 2024, a -6.42% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Global Health Limited Operating Cash Flow for the year ending March 31, 2023 was USD 78.42 M, a 91.29% change year over year.
  • Global Health Limited Operating Cash Flow for the year ending March 31, 2022 was USD 40.99 M, a 24.15% change year over year.
  • Global Health Limited Operating Cash Flow for the year ending March 31, 2021 was USD 33.02 M, a 42.13% change year over year.
  • Global Health Limited Operating Cash Flow for the year ending March 31, 2020 was USD 23.23 M, a 4.58% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
Loading...
SV Wall Street
NSE: MEDANTA.NS

Global Health Limited

CEO Mr. Pankaj Prakash Sahni
IPO Date Nov. 18, 2022
Location India
Headquarters The Medicity
Employees 9,052
Sector Health Care
Industries
Description

Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. It operates a network of four hospitals in Gurugram, Indore, Ranchi, and Lucknow under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurgaon, India.

Similar companies

BIKAJI.NS

Bikaji Foods International Limited

USD 7.96

0.75%

KIMS.NS

Krishna Institute of Medical Sciences Limited

USD 7.02

1.27%

CAMPUS.NS

Campus Activewear Limited

USD 3.14

0.11%

RAINBOW.NS

Rainbow Children's Medicare Limited

USD 16.41

-0.51%

StockViz Staff

February 1, 2025

Any question? Send us an email